title: Top 10 Things Primary Care Physicians Should Know About Maintenance Immunosuppression for Transplant Recipients.
abstract: The success of organ transplantation allows many transplant recipients to return to life similar to nontransplant patients. Their need for regular health care, including preventive medicine, has switched the majority of responsibilities for their health care from transplant specialists to primary care physicians. To take care of transplant recipients, it is critical for primary care physicians to be familiar with immunosuppressive medications, their side effects, and common complications in transplant recipients. Ten subjects are reviewed here in order to assist primary care physicians in providing optimal care for transplant recipients.
authors.affiliation: Department of Medicine, College of Medicine, University of Arizona, Tucson and Arizona Kidney Disease and Hypertension Center, Tucson. Electronic address: lienhoward@gmail.com.
authors.forename: Yeong-Hau H
authors.initials: YH
authors.lastname: Lien
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000592:standards; D016572:Cyclosporine / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced / Q000150:complications / Q000276:immunology; D004347:Drug Interactions / Q000276:immunology; D016903:Drug Monitoring / Q000379:methods / Q000592:standards*; D017558:Elective Surgical Procedures / Q000009:adverse effects / Q000592:standards; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D055118:Medication Adherence; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D016377:Organ Transplantation / Q000009:adverse effects*; D010020:Osteonecrosis / Q000139:chemically induced / Q000188:drug therapy; D011086:Polycythemia / Q000188:drug therapy / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D011320:Primary Health Care / Q000379:methods / Q000592:standards*; D020123:Sirolimus / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D066027:Transplant Recipients; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology
chemical_list: D000305:Adrenal Cortex Hormones; D003271:Contraceptive Agents, Female; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus
keywords: Cyclosporine; Immunosuppression; Mycophenolate; Organ transplantation; Sirolimus; Tacrolimus